CORRECTION article

Front. Microbiol., 26 August 2021

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 12 - 2021 | https://doi.org/10.3389/fmicb.2021.756781

Corrigendum: Complete Genome Sequences of Two Novel KPC-2-Producing IncU Multidrug-Resistant Plasmids From International High-Risk Clones of Escherichia coli in China

  • 1. Department of Infectious Diseases, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China

  • 2. Medical College, Qingdao University, Qingdao, China

  • 3. Adicon Clinical Laboratories, Hangzhou, China

  • 4. Department of Pneumology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China

  • 5. Centre of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China

In the published article, there was an error in affiliation of the authors: Wenjia Fan and Hongying Pan. Instead of “Wenhao Wu1,2, Lingling Lu3, Wenjia Fan2, Chun Chen4, Dazhi Jin5, Hongying Pan2*and Xi Li5*,” it should be “Wenhao Wu1,2, Lingling Lu3, Wenjia Fan1, Chun Chen4, Dazhi Jin5, Hongying Pan1*and Xi Li5*.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

E. coli, KPC-2, IncU plasmid, high-risk clones, whole genome sequencing

Citation

Wu W, Lu L, Fan W, Chen C, Jin D, Pan H and Li X (2021) Corrigendum: Complete Genome Sequences of Two Novel KPC-2-Producing IncU Multidrug-Resistant Plasmids From International High-Risk Clones of Escherichia coli in China. Front. Microbiol. 12:756781. doi: 10.3389/fmicb.2021.756781

Received

11 August 2021

Accepted

11 August 2021

Published

26 August 2021

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

12 - 2021

Updates

Copyright

*Correspondence: Xi Li Hongying Pan

This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics